HOTAIR and infectious disease: Interestingly, in HCV-4 patients, HOTAIR could serve as a risk assessment biomarker following direct-acting antiviral therapy [148], suggesting that HOTAIR has potential as a biomarker for the treatment or risk evaluation of infectious diseases.